PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-16.79%
Negative net income growth while AVGO stands at 21.13%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.19%
Less D&A growth vs. AVGO's 26.09%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-137.46%
Negative yoy deferred tax while AVGO stands at 216.67%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
8.16%
SBC growth well above AVGO's 10.00%. Michael Burry would flag major dilution risk vs. competitor’s approach.
255.98%
Well above AVGO's 52.05% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-4829.52%
Both yoy AR lines negative, with AVGO at -23.26%. Martin Whitman would suspect an overall sector lean approach or softer demand.
122.70%
Inventory growth well above AVGO's 95.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-130.94%
Both negative yoy AP, with AVGO at -18.18%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
401.23%
Growth well above AVGO's 147.62%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-351210.00%
Both negative yoy, with AVGO at -500.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
148.51%
Operating cash flow growth above 1.5x AVGO's 54.74%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-6.88%
Negative yoy CapEx while AVGO is 12.31%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-34.78%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
61.73%
Liquidation growth of 61.73% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
22.63%
Lower net investing outflow yoy vs. AVGO's 87.67%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-3.13%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.